Reefer MEDness

Can cannabinoids change the future of concussion care in contact sports? Kirk follows up with Dr. Patrick Neary, PhD, from the University of Regina, to see how his NFL-funded research into CBD, concussions, pain management, and athlete health is going now that the study has moved from planning to execution. Recorded on 4/20, let's dive in: can CBD help reduce concussion risk, support brain recover...

What happens when medical cannabis is legal—but medical patients are still left without meaningful guidance? Part 2 of Kirk’s conversation with Ted Smith of the Victoria Cannabis Buyers Club explores the widening gap between legalization, Health Canada’s medical cannabis framework, and the real-world needs of patients. It seems many Canadians using cannabis for medical reasons are now being pushed...

What happens when a cannabis compassion club gets raided again despite previous Supreme Court decisions on their side, fervent public support, and years after cannabis legalization? Kirk visits Ted Smith at the Victoria Cannabis Buyers Club (VCBC) just days after its latest raid. Ted discusses ongoing legal challenges, compassionate access, Rick Simpson Oil (RSO), cannabis harm reduction, pharmaci...

Why is cannabis research so much harder than researching other medicines? Dr. Lauren Kelly—Associate Professor at the University of Manitoba, Cannabis researcher and Trialist, CCIC President, and CMCN Co-Lead—joins Reefer MEDness to explain why cannabis clinical trials face unique barriers in Canada. Learn how Health Canada regulations, GMP vs GPP standards, product consistency challenges, and gap...

Can medical cannabis help children—and what does the evidence actually show? Pediatric pharmacologist, Dr. Lauren Kelly, joins Trevor and Kirk to discuss medical cannabis in children. This wide ranging conversation includes discussion about epilepsy, autism, pediatric oncology, and the unique challenges of studying cannabinoids during development. Learn what researchers know about CBD, THC & k...

Could CBD help your dog with seizures, chronic pain, or relentless itching—and is THC really as dangerous for pets as we've been told? Trevor and Kirk sit down with Dr. Kevin Toman, a California-based veterinarian specializing in pet longevity and preventive care. Drawing on more than 40 years of veterinary experience, Dr. Kevin explains why CBD has become an important tool in his practice, partic...

Can full-spectrum cannabis work better than isolates — even if it tastes worse? In Part 2 with Seann Poli of JAN Rx, Trevor explores CBG, CBC, acidic cannabinoids, the entourage effect, veteran cannabis care, and why cannabis companies are increasingly filling healthcare roles traditionally held by pharmacists and nurses. Plus: a new “rocket fuel” cannabinoid blend, hormone-focused cannabis produc...

Can medical cannabis care become more personalized and patient-focused? Trevor and Kirk talk with Seann Poli of JANrx about raising capital during the early LP boom to building a 100% Canadian, independent medical cannabis company. Seann tells us about veteran cannabis care, challenges dealing with insurance companies, CBD/CBN products, medical cannabis education, and the future of holistic cannab...

Tightened Spotify / Apple Podcasts Description Can medical cannabis help patients reduce opioids, sleep better, and reclaim quality of life? In Part 2 of Trevor and Kirk’s conversation with German physician Dr. Vlad Gavril, they continue to explore cannabinoid medicine in Germany. Dr. Vlad discusses chronic pain, insomnia, cannabis smoking vs vaping, opioid reduction, and the evolving German canna...

A German cannabis physician, a nurse and a pharmacist walk into a bar...I mean a podcast. In this fascinating episode of Reefer MEDness, Trevor (pharmacist) and Kirk (registered nurse) sit down with Dr. Vlad Gavril, a German GP specializing in cannabinoid therapy, to explore how medical cannabis is transforming patient care in Germany. Dr. Vlad explains how Germany’s partial cannabis legalization...

Can a massive data project finally answer the biggest questions about medical cannabis? In Part 2 of our conversation with Dr. Johannes Thrul, we explore the National Cannabis Study, an ambitious effort to build a global repository of cannabis research and real-world patient data. From standardized tools like the Cannabis Use Questionnaire to combining datasets from multiple studies, this project...

What truth can big data unlock about medical cannabis? Dr. Johannes Thrul from Johns Hopkins talks about cannabis use disorder, psychiatric risks, THC intoxication, and the groundbreaking Cannabis Health Research Initiative. The ambitious Cannabis Health Research Initiative is a groundbreaking effort to build a national medical cannabis registry and research database. Dr. Thrul shares how the Nati...

What will it take for cannabis and natural compounds to truly enter the mainstream—from toothpaste to energy drinks? In Part 2 of Trevor and Kirk’s conversation with biotech financier and cannabis strategist David Traylor, they discuss how major corporations might explore integrating cannabinoids like CBN and CBD and other natural products into everyday consumer products. David explains how his Sk...

Can big brands explore cannabis, & psychedelics without saying it out loud? What happens when cannabis and natural compounds expertise, a global network, and AI-driven product strategy collide? David Traylor of Golden Eagle Partners introduces Skunk Works Nature AI. This new venture helps major consumer brands quietly explore cannabinoids and other natural compounds. Does a large beverage comp...

What if the fastest way to feel cannabis effects isn’t through your lungs… but through your nose? Trevor and Kirk explore the science behind a unique cannabis accessory: the Nozzr, a nasal inhalation device designed to deliver vaporized cannabis through the nose rather than the mouth. Inventor and respiratory therapist Yvette Webb shares how the idea emerged during the COVID-19 pandemic while rese...

How terpenes, cannabinoids, and topical cannabis science helped an MS patient create a cannabis wellness brand. A deep dive into terpene-based cannabis medicine.

What are future pharmacists really being taught about cannabis—and is the stigma finally disappearing? In this episode of Reefer MEDness, Trevor and Kirk sit down with a University of Manitoba pharmacy student Ariana to explore how cannabis is being taught in modern healthcare education. From cannabinoid receptors (CB1/CB2) to drug interactions via CYP3A4, this conversation breaks down how cannabi...

Join us on this exciting reunion with our friends at High on Homegrown! It has been five long years since our first appearance on High on Homegrown found in our early days of Episode 60. Macky interviews Kirk and Trevor. They dive deep into the fascinating world of medical cannabis, podcasting, and a bunch of entertaining, random topics you will find most fascinating. Can dog poop get you high? Wh...

Does gamma irradiation destroy THC? We explore cannabis mold, mycotoxins, safety standards, and whether irradiation protects or harms medical cannabis.

Does irradiated cannabis still contain mold spores? In this deep-dive episode, Trevor and Kirk explore the science behind cannabis irradiation, fungal contamination, and the hidden risks of mycotoxins. Dr. Saji George and Mamta Rani from McGill University break down how gamma irradiation is used to sterilize cannabis—and why even this industry-standard sterilization may not eliminate all harmful f...

Can a centuries-old cannabis culture survive legalization? In this exclusive episode, Reefer MEDness shares a rare anonymous interview with a SOMACAN quality manager inside Morocco’s emerging legal cannabis industry. Kirk and Mr. Anonymous share a car ride through the Rif Mountains and Mr. Anonymous reveals how local farmers are transitioning from black-market hash production into regulated medica...

Can Morocco’s famous hash industry survive pharmaceutical regulation? In Part 2 of Episode 166, Trevor and Kirk continue their conversation with Jan van Weenen, a European cannabis veteran helping transform Morocco’s ancient hash market into a GMP-compliant pharmaceutical industry. From heavy metals in Rif Mountain soil to pricing battles between farmers, co-ops, and manufacturers, this episode re...

Inside Morocco’s cannabis industry: pharmaceutical standards, heavy metals, GACP/GMP hurdles, and why legal cannabis isn’t always legitimate.

Dr. Dror Robinson’s five-year longitudinal Israeli study goal was to evaluate inhaled cannabis use for diabetic neuropathy. He found it works and he now believes all diabetics should be inhaling cannabis flower. The study can be faulted for the lack of diversity with the 52 individuals sampled, however the study presents a 97% sample retention, and the evidence suggests every participant benefitte...

What does medical cannabis look like when a King gets involved? Morocco, a country historically known for exporting outstanding Hashish, must import medicinal cannabis from aboard because its local crop doesn't meet the quality standards of Europe. The King of Morocco wants to bring Moroccan cannabis up to Good Agricultural and Collection Practices (GACP) so it can be used locally and be exported....